Evidence map›Paper›PMID 17712401›Full record

ArticlePloS one2007

HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.

Gilles Mirambeau, Sébastien Lyonnais, Dominique Coulaud, Laurence Hameau, Sophie Lafosse, Josette Jeusset, Isabelle Borde, Michèle Reboud-Ravaux, Tobias Restle, Robert J Gorelick and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.Microbiology and molecular biology reviews : MMBR · 2016
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Reaction-diffusion basis of retroviral infectivity.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2016
    Article
  8. Article
  9. Article
  10. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.Current topics in microbiology and immunology · 2015
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Gilles MirambeauLaboratoire de Microscopie Moléculaire, UMR 8126: Interactions Moléculaires et Cancer, CNRS, Université Paris Sud-Institut de Cancérologie Gustave Roussy, Villejuif, France; Division de Biochimie, UFR des Sciences de la Vie, Université Pierre et Marie Curie-Paris, France. gilles.mirambeau@free.fr
Sébastien Lyonnais
Dominique Coulaud
Laurence Hameau
Sophie Lafosse
Josette Jeusset
Isabelle Borde
Michèle Reboud-Ravaux
Tobias Restle
Robert J Gorelick
Eric Le Cam
Centre National de la Recherche Scientifique · FRInstitut Gustave Roussy · FRSorbonne Université · FRUniversité Paris-Sud · FRScience Applications International Corporation (United States) · USUniversity Hospital Schleswig-Holstein · DE

Funding

NCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400
6 · The paper itself

Abstract

The HIV-1 nucleocapsid is formed during protease (PR)-directed viral maturation, and is transformed into pre-integration complexes following reverse transcription in the cytoplasm of the infected cell. Here, we report a detailed transmission electron microscopy analysis of the impact of HIV-1 PR and reverse transcriptase (RT) on nucleocapsid plasticity, using in vitro reconstitutions. After binding to nucleic acids, NCp15, a proteolytic intermediate of nucleocapsid protein (NC), was processed at its C-terminus by PR, yielding premature NC (NCp9) followed by mature NC (NCp7), through the consecutive removal of p6 and p1. This allowed NC co-aggregation with its single-stranded nucleic-acid substrate. Examination of these co-aggregates for the ability of RT to catalyse reverse transcription showed an effective synthesis of double-stranded DNA that, remarkably, escaped from the aggregates more efficiently with NCp7 than with NCp9. These data offer a compelling explanation for results from previous virological studies that focused on i) Gag processing leading to nucleocapsid condensation, and ii) the disappearance of NCp7 from the HIV-1 pre-integration complexes. We propose that HIV-1 PR and RT, by controlling the nucleocapsid architecture during the steps of condensation and dismantling, engage in a successive nucleoprotein-remodelling process that spatiotemporally coordinates the pre-integration steps of HIV-1. Finally we suggest that nucleoprotein remodelling mechanisms are common features developed by mobile genetic elements to ensure successful replication.

Indexed as

Binding SitesDNA, Single-StrandedDNA, ViralGenome, ViralHIV-1HIV ProteaseHIV Reverse TranscriptaseKineticsModels, MolecularNucleocapsidRNA, ViralDNA, Single-StrandedDNA, ViralHIV ProteaseHIV Reverse Transcriptasep16 protease, Human immunodeficiency virus 1reverse transcriptase, Human immunodeficiency virus 1RNA, Viral

Identifiers

PMID17712401
PMCPMC1940317
OpenAlexW2088345598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.